VJHemOnc is committed to improving our service to you

ICML 2019 | Road ahead for immunotherapy in Hodgkin lymphoma: bispecifics & CAR-T

VJHemOnc is committed to improving our service to you

Stephen Ansell

Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN, discusses the road ahead for immunotherapy in Hodgkin lymphoma, touching upon bispecifics and CAR T-cells. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter